News Center

Volvo Cars CEO says its customers must pay for rising tariffs

Volvo Cars CEO says its customers must pay for rising tariffs

By Marie Mannes and Nora Eckert STOCKHOLM/DETROIT (Reuters) -Volvo Cars CEO Hakan Samuelsson said on Friday that its customers would have to pay a large part of tariff-related cost increases, and that it could become impossible to import one of its most affordable cars to the United States if levies increase. U.S. President Donald Trump on Friday said he was recommending a straight 50% tariff ...

2025-05-24 00:29:56
United Bank ratings affirmed and outlook revised to stable by Moody’s

United Bank ratings affirmed and outlook revised to stable by Moody’s

Investing.com -- Moody’s Ratings has confirmed all ratings and assessments for United Bank, a subsidiary of United Bankshares (NASDAQ:UBSI), Inc. The affirmed ratings include the bank’s long-term and short-term local and foreign currency counterparty risk ratings of A3 and Prime-2, respectively. The bank’s long- and short-term local currency deposit ratings of A1 and Prime-1, respectively, ...

2025-05-24 00:28:40
Greece stocks lower at close of trade; Athens General Composite down 1.42%

Greece stocks lower at close of trade; Athens General Composite down 1.42%

Investing.com – Greece stocks were lower after the close on Friday, as losses in the Banking, Telecoms and Household sectors led shares lower.At the close in Athens, the Athens General Composite fell 1.42%.The best performers of the session on the Athens General Composite were Optima bank SA (AT:OPTIMAr), which rose 3.04% or 0.56 points to trade at 19.00 at the close. Meanwhile, Thessaloniki W ...

2025-05-24 00:27:26
COVID shots should target newer strains of JN.1 variant, US FDA advisers say

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

By Puyaan Singh and Christy Santhosh (Reuters) - U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. COVID vaccine makers are seeing increased regulatory scrutiny under the new FDA leadership, facing tighter requirements for their shots that could increase expenses. FDA Commiss ...

2025-05-24 00:26:10